Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
RESEARCH TOOLSreports
Holding AVIR?
Track your performance easily
Atea Pharmaceuticals (AVIR) Ownership Overview
11.47% Insiders
14.58% Mutual Funds
27.46% Other Institutional Investors
11.20% ETFs
35.29% Public Companies and Individual Investors
The ownership structure of Atea Pharmaceuticals (AVIR) stock is a mix of institutional, retail, and individual investors. Approximately 53.24% of the company’s stock is owned by Institutional Investors, 11.47% is owned by Insiders, and 35.29% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 17, 2025 | Franklin Berger Director | xxxxxxxxxxxxx | $81450 |
| Dec 12, 2024 | Franklin Berger Director | xxxxxxxxxxxxx | $1021281 |
| Jun 21, 2024 | Bruce Polsky Director | xxxxxxxxxxxxx | $61053 |
| Jun 07, 2024 | Jean Pierre Sommadossi President, Ceo, And Chairman,director | xxxxxxxxxxxxx | $4024 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $346249 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,162,914 | Insider | 9.60% | 25,713,179 | |
| 4,277,680 | Institution | 5.06% | 13,474,692 | |
| 3,677,608 | Institution | 4.35% | 11,584,465 | |
| 3,639,660 | Institution | 4.31% | 11,464,929 | |
| 1,811,377 | Institution | 2.14% | 5,705,838 | |
| 958,300 | Institution | 1.13% | 3,018,645 | |
| 876,763 | Institution | 1.04% | 2,761,803 | |
| 856,242 | Institution | 1.01% | 2,697,162 | |
| 773,494 | Institution | 0.92% | 2,436,506 | |
| 670,208 | Insider | 0.79% | 2,111,155 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,639,660 | Institution | 4.31% | 11,464,929 | |
| 1,811,377 | Institution | 2.14% | 5,705,838 | |
| 958,300 | Institution | 1.13% | 3,018,645 | |
| 876,763 | Institution | 1.04% | 2,761,803 | |
| 856,242 | Institution | 1.01% | 2,697,162 | |
| 773,494 | Institution | 0.92% | 2,436,506 | |
| 549,380 | Institution | 0.65% | 1,730,547 | |
| 502,608 | Institution | 0.60% | 1,583,215 | |
| 376,458 | Institution | 0.45% | 1,185,843 | |
| 353,892 | Institution | 0.42% | 1,114,760 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,363,327 | Institution | 2.80% | 8,082,578 | |
| 2,052,309 | Institution | 2.43% | 6,464,773 | |
| 1,284,504 | Institution | 1.52% | 4,393,004 | |
| 726,132 | Institution | 0.86% | 2,287,316 | |
| 468,234 | Institution | 0.55% | 1,474,937 | |
| 385,220 | Institution | 0.46% | 1,232,704 | |
| 362,125 | Institution | 0.43% | 1,238,468 | |
| 209,203 | Institution | 0.25% | 715,474 | |
| 178,891 | Institution | 0.21% | 563,507 | |
| 170,872 | Institution | 0.20% | 538,247 |
FAQ
Who Owns Atea Pharmaceuticals (AVIR)?
According to the latest TipRanks data, approximately 27.46% of the company's stock is held by institutional investors, 11.47% is held by insiders, and 35.29% is held by retail investors.
What percentage of Atea Pharmaceuticals (AVIR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.46% of Atea Pharmaceuticals (AVIR) stock is held by institutional investors.
What percentage of Atea Pharmaceuticals (AVIR) stock is held by retail investors?
According to the latest TipRanks data, approximately 35.29% of Atea Pharmaceuticals (AVIR) stock is held by retail investors.
Who owns the most shares of Atea Pharmaceuticals (AVIR)?
Jean-Pierre Sommadossi owns the most shares of Atea Pharmaceuticals (AVIR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.